Sale!

ARHGEF9 Gene Early Infantile Epileptic Encephalopathy Type 8 Genetic Test

Original price was: $700.Current price is: $500.

-29%

The ARHGEF9 Gene Early Infantile Epileptic Encephalopathy Type 8 NGS Genetic DNA Test is a specialized diagnostic tool that identifies mutations in the ARHGEF9 gene responsible for severe neurological disorders in infants. This comprehensive test utilizes Next-Generation Sequencing (NGS) technology to detect genetic variations associated with developmental delays, seizures, and cognitive impairments. Early diagnosis through this $500 USD test enables timely intervention and personalized treatment strategies for affected infants. The test is particularly valuable for families with a history of neurological conditions or infants showing symptoms of epileptic encephalopathy. Results are typically available within 3-4 weeks, providing crucial information for healthcare providers to develop targeted care plans and genetic counseling for families.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

ARHGEF9 Gene Early Infantile Epileptic Encephalopathy Type 8 NGS Genetic DNA Test

Comprehensive Genetic Testing for Severe Neurological Disorders

The ARHGEF9 Gene Early Infantile Epileptic Encephalopathy Type 8 NGS Genetic DNA Test represents a breakthrough in pediatric neurological diagnostics. This advanced genetic screening utilizes cutting-edge Next-Generation Sequencing (NGS) technology to identify mutations in the ARHGEF9 gene, which plays a critical role in brain development and neurological function. Early Infantile Epileptic Encephalopathy Type 8 is a severe condition characterized by treatment-resistant seizures, developmental regression, and significant cognitive impairments that typically manifest within the first months of life.

What This Test Measures and Detects

This specialized genetic test specifically targets the ARHGEF9 gene located on the X chromosome, which encodes for collybistin—a protein essential for proper synaptic function in the brain. The test detects:

  • Pathogenic variants and mutations in the ARHGEF9 gene
  • Single nucleotide polymorphisms (SNPs) associated with neurological dysfunction
  • Deletions, duplications, and insertions affecting gene function
  • X-linked inheritance patterns crucial for family genetic counseling

Who Should Consider This Test

This genetic test is recommended for infants and children presenting with:

  • Early-onset seizures within the first 6 months of life
  • Developmental regression or stagnation
  • Hypotonia (reduced muscle tone) and motor coordination issues
  • Intellectual disability and cognitive impairments
  • Family history of X-linked neurological disorders
  • Unexplained encephalopathy or brain dysfunction
  • Abnormal EEG patterns consistent with epileptic encephalopathy

Significant Benefits of Early Genetic Testing

Early diagnosis through ARHGEF9 gene testing provides numerous advantages:

  • Accurate Diagnosis: Confirms the specific genetic cause of neurological symptoms
  • Personalized Treatment: Enables targeted therapeutic approaches based on genetic findings
  • Family Planning: Provides crucial information for genetic counseling and future family planning
  • Prognostic Information: Helps predict disease progression and potential outcomes
  • Early Intervention: Facilitates timely implementation of developmental therapies
  • Reduced Diagnostic Odyssey: Minimizes unnecessary medical testing and procedures

Understanding Your Test Results

Our comprehensive genetic counseling team will help you interpret your results:

  • Positive Result: Indicates a pathogenic mutation in the ARHGEF9 gene, confirming the diagnosis of Early Infantile Epileptic Encephalopathy Type 8
  • Negative Result: Suggests no detectable mutations in the ARHGEF9 gene, though other genetic causes may need investigation
  • Variant of Uncertain Significance (VUS): Identifies genetic changes whose clinical significance is currently unknown, requiring ongoing monitoring
  • Carrier Status: For family members, identifies individuals who carry the mutation but may not show symptoms

Test Pricing and Details

Test Feature Details
Test Name ARHGEF9 Gene Early Infantile Epileptic Encephalopathy Type 8 NGS Genetic DNA Test
Discount Price $500 USD
Regular Price $700 USD
Turnaround Time 3 to 4 Weeks
Sample Type Blood, Extracted DNA, or One Drop Blood on FTA Card
Testing Method Next-Generation Sequencing (NGS) Technology

Pre-Test Requirements

Before scheduling your test, please ensure:

  • Complete clinical history of the patient
  • Genetic counseling session to create a detailed family pedigree chart
  • Documentation of affected family members with similar neurological symptoms
  • Referral from a neurologist or genetic specialist

Nationwide Accessibility

We proudly serve patients across the United States with convenient testing locations in all major cities including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more. Our network of certified genetic counselors and neurological specialists ensures comprehensive care regardless of your location.

Take the Next Step Toward Answers

Don’t let uncertainty about your child’s neurological health continue. Early diagnosis can make a significant difference in treatment outcomes and quality of life. Our expert team is ready to guide you through the testing process and provide the answers your family deserves.

Call or WhatsApp us today at +1(267) 388-9828 to schedule your genetic counseling session and book the ARHGEF9 Gene Test. Take control of your child’s neurological health with comprehensive genetic testing from America’s trusted genetics laboratory.